Click Here to take our survey.
The Leading Online Community of Pharmaceutical Marketing Experts
Newsletter | Conferences | Podcasts | Glossary | Surveys | Blog | Advertising Information | Contact Us
 "Must Read Blog for Insiders." -- Wall Street Journal |
 Current Issue of Pharma Marketing News Available!
Search the Entire Pharma Marketing Forums Site
|
|
|||||||
| Regulatory Affairs News and topics related to marketing laws, regulations and guidelines. Includes news feeds from FDA, including press releases, advisory committee meeting announcements, and drug safety notices. |
 |
|
|
Thread Tools | Rate Thread | Display Modes |
|
#1
28th April 2009, 12:00 AM
|
|||
|
|||
FDA Authorizes Emergency Use of Influenza Medicines, Diagnostic Test in Response to S
The U.S. Food and Drug Administration, in response to requests from the U.S. Centers for Disease Control and Prevention, has issued Emergency Use Authorizations (EUAs) to make available to public health and medical personnel important diagnostic and therapeutic tools to identify and respond to the swine flu virus under certain circumstances. The agency issued these EUAs for the use of certain Relenza and Tamiflu antiviral products, and for the rRT-PCR Swine Flu Panel diagnostic test.
More... 
|
|
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | Rate This Thread |
Linear Mode
|
|
All times are GMT -4. The time now is 03:14 AM.